{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:11:52Z","timestamp":1793938312618,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korean government","award":["RS-2023-00245268"],"award-info":[{"award-number":["RS-2023-00245268"]}]},{"name":"Korean government","award":["2022R1A2C2005916"],"award-info":[{"award-number":["2022R1A2C2005916"]}]},{"name":"CHA Bundang Medical Center","award":["BDCHA R&D 2023-301"],"award-info":[{"award-number":["BDCHA R&D 2023-301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-74060-w","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:08:05Z","timestamp":1728302885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prognostic value of body composition measures in breast cancer patients treated with chemotherapy"],"prefix":"10.1038","volume":"14","author":[{"given":"Hogyeong","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyunSeo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooyeol","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonchul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"issue":"3","key":"74060_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"74060_CR2","unstructured":"National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Program. Cancer Stat Facts: Female Breast Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. (2023). Accessed 18 March 2024."},{"issue":"12","key":"74060_CR3","first-page":"825","volume":"10","author":"MB Lustberg","year":"2012","unstructured":"Lustberg, M. B. Management of neutropenia in cancer patients. Clin. Adv. Hematol. Oncol.10(12), 825\u2013826 (2012).","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"Suppl 5","key":"74060_CR4","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/s1098-3597(06)80054-2","volume":"8","author":"GH Lyman","year":"2006","unstructured":"Lyman, G. H. Risks and consequences of chemotherapy-induced neutropenia. Clin. Cornerstone8(Suppl 5), S12\u2013S18. https:\/\/doi.org\/10.1016\/s1098-3597(06)80054-2 (2006).","journal-title":"Clin. Cornerstone"},{"issue":"1","key":"74060_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10549-014-2977-8","volume":"146","author":"C Arce-Salinas","year":"2014","unstructured":"Arce-Salinas, C. et al. Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients. Breast Cancer Res. Treat.146(1), 183\u2013188. https:\/\/doi.org\/10.1007\/s10549-014-2977-8 (2014).","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"74060_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jss.2015.03.088","volume":"198","author":"VC Herlevic","year":"2015","unstructured":"Herlevic, V. C. et al. Breast cancer outcomes in a population with high prevalence of obesity. J. Surg. Res.198(2), 371\u2013376. https:\/\/doi.org\/10.1016\/j.jss.2015.03.088 (2015).","journal-title":"J. Surg. Res."},{"issue":"35","key":"74060_CR7","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1200\/JCO.2016.67.4051","volume":"34","author":"JA Ligibel","year":"2016","unstructured":"Ligibel, J. A. & Wollins, D. American Society of Clinical Oncology obesity initiative: Rationale, progress, and future directions. J. Clin. Oncol.34(35), 4256\u20134260. https:\/\/doi.org\/10.1200\/JCO.2016.67.4051 (2016).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"74060_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1158\/1055-9965.EPI-15-0334-T","volume":"25","author":"RS Cecchini","year":"2016","unstructured":"Cecchini, R. S. et al. Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG oncology\/NSABP B-30, B-31, B-34, and B-38. Cancer Epidemiol. Biomark. Prev.25(1), 51\u201359. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0334-T (2016).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"74060_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10549-016-3923-8","volume":"159","author":"A Gennari","year":"2016","unstructured":"Gennari, A. et al. Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy. Breast Cancer Res. Treat.159(1), 79\u201386. https:\/\/doi.org\/10.1007\/s10549-016-3923-8 (2016).","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"74060_CR10","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.biocel.2013.06.016","volume":"45","author":"V Baracos","year":"2013","unstructured":"Baracos, V. & Kazemi-Bajestani, S. M. Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses. Int. J. Biochem. Cell. Biol.45(10), 2302\u20132308. https:\/\/doi.org\/10.1016\/j.biocel.2013.06.016 (2013).","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"5","key":"74060_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol.12(5), 489\u2013495. https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7 (2011).","journal-title":"Lancet Oncol."},{"key":"74060_CR12","doi-asserted-by":"publisher","unstructured":"Murray, T. \u00c9., Williams, D. & Lee, M. J. Osteoporosis, obesity, and sarcopenia on abdominal CT: A review of epidemiology, diagnostic criteria, and management strategies for the reporting radiologist. Abdom. Radiol. (N.Y.)42(9), 2376\u20132386. https:\/\/doi.org\/10.1007\/s00261-017-1124-5 (2017). Erratum in: Abdom. Radiol. (N.Y.) 2018;43(5):1281. https:\/\/doi.org\/10.1007\/s00261-017-1274-5.","DOI":"10.1007\/s00261-017-1124-5 10.1007\/s00261-017-1274-5"},{"issue":"4","key":"74060_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/cancers13040608","volume":"13","author":"T Iwase","year":"2021","unstructured":"Iwase, T. et al. The prognostic impact of body composition for locally advanced breast cancer patients who received neoadjuvant chemotherapy. Cancers (Basel)13(4), 608. https:\/\/doi.org\/10.3390\/cancers13040608 (2021).","journal-title":"Cancers (Basel)"},{"issue":"8","key":"74060_CR14","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado, C. M. et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin. Cancer Res.15(8), 2920\u20132926. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2242 (2009).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"74060_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","volume":"23","author":"SS Shachar","year":"2017","unstructured":"Shachar, S. S. et al. Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clin. Cancer Res.23(3), 658\u2013665. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0940 (2017).","journal-title":"Clin. Cancer Res."},{"key":"74060_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.09.001","volume":"54","author":"SM Kazemi-Bajestani","year":"2016","unstructured":"Kazemi-Bajestani, S. M., Mazurak, V. C. & Baracos, V. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Semin. Cell Dev. Biol.54, 2\u201310. https:\/\/doi.org\/10.1016\/j.semcdb.2015.09.001 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"74060_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","volume":"57","author":"SS Shachar","year":"2016","unstructured":"Shachar, S. S., Williams, G. R., Muss, H. B. & Nishijima, T. F. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur. J. Cancer57, 58\u201367. https:\/\/doi.org\/10.1016\/j.ejca.2015.12.030 (2016).","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"74060_CR18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11764-012-0234-x","volume":"6","author":"A Villase\u00f1or","year":"2012","unstructured":"Villase\u00f1or, A. et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J. Cancer Surv.6(4), 398\u2013406. https:\/\/doi.org\/10.1007\/s11764-012-0234-x (2012).","journal-title":"J. Cancer Surv."},{"key":"74060_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.breast.2016.10.014","volume":"31","author":"HN Rier","year":"2017","unstructured":"Rier, H. N. et al. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. Breast31, 9\u201315. https:\/\/doi.org\/10.1016\/j.breast.2016.10.014 (2017).","journal-title":"Breast"},{"issue":"3","key":"74060_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-019-05352-3","volume":"177","author":"GFP Aleixo","year":"2019","unstructured":"Aleixo, G. F. P., Williams, G. R., Nyrop, K. A., Muss, H. B. & Shachar, S. S. Muscle composition and outcomes in patients with breast cancer: Meta-analysis and systematic review. Breast Cancer Res. Treat.177(3), 569\u2013579. https:\/\/doi.org\/10.1007\/s10549-019-05352-3 (2019).","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"74060_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00520-017-3902-6","volume":"26","author":"E Deluche","year":"2018","unstructured":"Deluche, E. et al. Impact of body composition on outcome in patients with early breast cancer. Support Care Cancer26(3), 861\u2013868. https:\/\/doi.org\/10.1007\/s00520-017-3902-6 (2018).","journal-title":"Support Care Cancer"},{"issue":"6","key":"74060_CR22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","volume":"4","author":"BJ Caan","year":"2018","unstructured":"Caan, B. J. et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol.4(6), 798\u2013804. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0137 (2018).","journal-title":"JAMA Oncol."},{"issue":"7","key":"74060_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado, C. M. et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol.9(7), 629\u2013635. https:\/\/doi.org\/10.1016\/S1470-2045(08)70153-0 (2008).","journal-title":"Lancet Oncol."},{"issue":"12","key":"74060_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin, L. et al. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol.31(12), 1539\u20131547. https:\/\/doi.org\/10.1200\/JCO.2012.45.2722 (2013).","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"74060_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.clbc.2014.02.003","volume":"14","author":"S Battisti","year":"2014","unstructured":"Battisti, S. et al. Modification of abdominal fat distribution after aromatase inhibitor therapy in breast cancer patients visualized using 3-D computed tomography volumetry. Clin. Breast Cancer14(5), 365\u2013370. https:\/\/doi.org\/10.1016\/j.clbc.2014.02.003 (2014).","journal-title":"Clin. Breast Cancer"},{"issue":"6","key":"74060_CR26","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/oby.22458","volume":"27","author":"PT Bradshaw","year":"2019","unstructured":"Bradshaw, P. T. et al. Adipose tissue distribution and survival among women with nonmetastatic breast cancer. Obesity (Silver Spring)27(6), 997\u20131004. https:\/\/doi.org\/10.1002\/oby.22458 (2019).","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"74060_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.21037\/tcr.2019.09.16","volume":"8","author":"MS Kim","year":"2019","unstructured":"Kim, M. S., Choi, Y. J. & Lee, Y. H. Visceral fat measured by computed tomography and the risk of breast cancer. Transl. Cancer Res.8(5), 199\u2013199. https:\/\/doi.org\/10.21037\/tcr.2019.09.16 (2019).","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"74060_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3348\/kjr.2020.1475","volume":"23","author":"MR Kwon","year":"2022","unstructured":"Kwon, M. R. et al. Impact of skeletal muscle loss and visceral obesity measured using serial CT on the prognosis of operable breast cancers in Asian Patients. Korean J. Radiol.23(2), 159\u2013171. https:\/\/doi.org\/10.3348\/kjr.2020.1475 (2022).","journal-title":"Korean J. Radiol."},{"issue":"6","key":"74060_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","volume":"20","author":"WJ Gradishar","year":"2022","unstructured":"Gradishar, W. J. et al. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw.20(6), 691\u2013722. https:\/\/doi.org\/10.6004\/jnccn.2022.0030 (2022).","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"74060_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3945\/ajcn.115.111203","volume":"102","author":"L Schweitzer","year":"2015","unstructured":"Schweitzer, L. et al. What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults?. Am. J. Clin. Nutr.102(1), 58\u201365. https:\/\/doi.org\/10.3945\/ajcn.115.111203 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"74060_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.compmedimag.2019.04.007","volume":"75","author":"S Dabiri","year":"2019","unstructured":"Dabiri, S. et al. Muscle segmentation in axial computed tomography (CT) images at the lumbar (L3) and thoracic (T4) levels for body composition analysis. Comput. Med. Imaging Graph.75, 47\u201355. https:\/\/doi.org\/10.1016\/j.compmedimag.2019.04.007 (2019).","journal-title":"Comput. Med. Imaging Graph."},{"key":"74060_CR32","unstructured":"National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (2017) version 5.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed 20 Jan 2023."},{"issue":"1","key":"74060_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00404-019-05168-y","volume":"300","author":"EF Solomayer","year":"2019","unstructured":"Solomayer, E. F. et al. Muscle mass loss in patients with metastatic breast cancer. Arch. Gynecol. Obstet.300(1), 201\u2013206. https:\/\/doi.org\/10.1007\/s00404-019-05168-y (2019).","journal-title":"Arch. Gynecol. Obstet."},{"issue":"7","key":"74060_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF02982704","volume":"12","author":"Y Rolland","year":"2008","unstructured":"Rolland, Y. et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J. Nutr. Health Aging12(7), 433\u2013450. https:\/\/doi.org\/10.1007\/BF02982704 (2008).","journal-title":"J. Nutr. Health Aging"},{"issue":"1","key":"74060_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ygyno.2021.05.004","volume":"162","author":"SI Kim","year":"2021","unstructured":"Kim, S. I. et al. Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric technique. Gynecol. Oncol.162(1), 72\u201379. https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.004 (2021).","journal-title":"Gynecol. Oncol."},{"issue":"7_suppl","key":"74060_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1200\/jco.2019.37.7_suppl.525","volume":"37","author":"KK Arora","year":"2019","unstructured":"Arora, K. K. et al. Increasing adipose burden in young men with metastatic testicular cancer following front-line cytotoxic chemotherapy. J. Clin. Oncol.37(7_suppl), 525\u2013525. https:\/\/doi.org\/10.1200\/jco.2019.37.7_suppl.525 (2019).","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"74060_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/0884533612457949","volume":"27","author":"S Tsai","year":"2012","unstructured":"Tsai, S. Importance of lean body mass in the oncologic patient. Nutr. Clin. Pract.27(5), 593\u2013598. https:\/\/doi.org\/10.1177\/0884533612457949 (2012).","journal-title":"Nutr. Clin. Pract."},{"issue":"3","key":"74060_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jgo.2018.10.009","volume":"10","author":"GR Williams","year":"2019","unstructured":"Williams, G. R., Rier, H. N., McDonald, A. & Shachar, S. S. Sarcopenia and aging in cancer. J. Geriatr. Oncol.10(3), 374\u2013377. https:\/\/doi.org\/10.1016\/j.jgo.2018.10.009 (2019).","journal-title":"J. Geriatr. Oncol."},{"key":"74060_CR39","doi-asserted-by":"publisher","unstructured":"Baumgartner, R. N. et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol.147(8), 755\u2013763. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009520 (1998). Erratum in: Am J Epidemiol 1999 Jun 15;149(12):1161.","DOI":"10.1093\/oxfordjournals.aje.a009520"},{"issue":"116 Suppl 7A","key":"74060_CR40","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1016\/j.amjmed.2003.12.008","volume":"5","author":"K Knight","year":"2004","unstructured":"Knight, K., Wade, S. & Balducci, L. Prevalence and outcomes of anemia in cancer: A systematic review of the literature. Am. J. Med.5(116 Suppl 7A), 11S-26S. https:\/\/doi.org\/10.1016\/j.amjmed.2003.12.008 (2004).","journal-title":"Am. J. Med."},{"issue":"5","key":"74060_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1152\/japplphysiol.00629.2013","volume":"115","author":"PM Tiidus","year":"2013","unstructured":"Tiidus, P. M., Lowe, D. A. & Brown, M. Estrogen replacement and skeletal muscle: Mechanisms and population health. J. Appl. Physiol.115(5), 569\u2013578. https:\/\/doi.org\/10.1152\/japplphysiol.00629.2013 (2013).","journal-title":"J. Appl. Physiol."},{"issue":"8","key":"74060_CR42","first-page":"3940","volume":"43","author":"MJ Reed","year":"1983","unstructured":"Reed, M. J., Cheng, R. W., Noel, C. T., Dudley, H. A. & James, V. H. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Cancer Res.43(8), 3940\u20133943 (1983).","journal-title":"Cancer Res."},{"key":"74060_CR43","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin.74(1), 12\u201349. https:\/\/doi.org\/10.3322\/caac.21820 (2024). Erratum in: CA Cancer J Clin. 2024 Mar-Apr;74(2):203. https:\/\/doi.org\/10.3322\/caac.21830.","DOI":"10.3322\/caac.21820 10.3322\/caac.21830"},{"issue":"10125","key":"74060_CR44","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani, C. et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet391(10125), 1023\u20131075. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3 (2018).","journal-title":"Lancet"},{"key":"74060_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exger.2015.06.002","volume":"69","author":"S Tyrovolas","year":"2015","unstructured":"Tyrovolas, S. et al. The role of muscle mass and body fat on disability among older adults: A cross-national analysis. Exp. Gerontol.69, 27\u201335. https:\/\/doi.org\/10.1016\/j.exger.2015.06.002 (2015).","journal-title":"Exp. Gerontol."},{"issue":"2","key":"74060_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/oby.20607","volume":"22","author":"KM Beavers","year":"2014","unstructured":"Beavers, K. M. et al. Effect of an 18-month physical activity and weight loss intervention on body composition in overweight and obese older adults. Obesity (Silver Spring)22(2), 325\u2013331. https:\/\/doi.org\/10.1002\/oby.20607 (2014).","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"74060_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.amjmed.2014.02.007","volume":"127","author":"P Srikanthan","year":"2014","unstructured":"Srikanthan, P. & Karlamangla, A. S. Muscle mass index as a predictor of longevity in older adults. Am. J. Med.127(6), 547\u2013553. https:\/\/doi.org\/10.1016\/j.amjmed.2014.02.007 (2014).","journal-title":"Am. J. Med."},{"issue":"4","key":"74060_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12149-022-01716-w","volume":"36","author":"M Bauckneht","year":"2022","unstructured":"Bauckneht, M. et al. Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223. Ann. Nucl. Med.36(4), 373\u2013383. https:\/\/doi.org\/10.1007\/s12149-022-01716-w (2022).","journal-title":"Ann. Nucl. Med."},{"key":"74060_CR49","doi-asserted-by":"publisher","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing48(1), 16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169 (2019). Erratum in: Age Ageing. 2019 Jul 1;48(4):601. https:\/\/doi.org\/10.1093\/ageing\/afz046.","DOI":"10.1093\/ageing\/afy169 10.1093\/ageing\/afz046"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74060-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74060-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74060-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T15:13:58Z","timestamp":1728573238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74060-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["74060"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74060-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23309"}}